Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Yih Jong Chern"'
Autor:
Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 100-109 (2023)
Background/Aims Exacerbating factors of ulcerative colitis (UC) are multiple and complex with individual influence. We aimed to evaluate the efficacy of disease control by searching and restricting inflammation trigger factors of UC relapse individua
Externí odkaz:
https://doaj.org/article/44e5edc0bbd240b0ab3cb45b8ec54a82
Autor:
Li-Yang Chan, Yih-Jong Chern, Yu-Jen Hsu, Bor-Kang Jong, I-Li Lai, Pao-Shiu Hsieh, Chun-Kai Liao, Jeng-Fu You
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Purpose Conventional minimally invasive surgery requires mini-laparotomy to extract the pathological specimen. However, by using a natural orifice as the delivery route, natural orifice specimen extraction (NOSE) surgery avoids the need for
Externí odkaz:
https://doaj.org/article/d2103c88e44045788ca70b346351c01c
Autor:
Ting‐Yu Chiang, Yu‐Jen Hsu, Yih‐Jong Chern, Chun‐Kai Liao, Wen‐Sy Tsai, Pao‐Shiu Hsieh, Hung‐Chih Hsu, Yu‐Fen Lin, Hsiu‐Lan Lee, Jeng‐Fu You
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Purpose Low anterior resection syndrome (LARS) has had many impacts on the lives of patients and substantial differences in emotional and social functions. The aim of this study was to investigate the correlation analysis of different person
Externí odkaz:
https://doaj.org/article/52db6136933649f7b2c5bedee7ec3f5a
Autor:
Li-Ming Wang, Bor-Kang Jong, Chun-Kai Liao, Ya-Ting Kou, Yih-Jong Chern, Yu-Jen Hsu, Pao-Shiu Hsieh, Wen-Sy Tsai, Jeng-Fu You
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Few studies have evaluated the feasibility and safety of intracorporeal anastomosis (IA) for left hemicolectomy. Here, we aimed to investigate the potential advantages and disadvantages of laparoscopic left hemicolectomy with IA a
Externí odkaz:
https://doaj.org/article/e7cedd22ee134618bad6a6125d42b2e0
Autor:
Yu-Jen Hsu, Yen-Lin Yu, Jing-Rong Jhuang, Jeng-Fu You, Chun-Kai Liao, Wen-Sy Tsai, Yi-Ping Pan, Yih-Jong Chern
Publikováno v:
International Journal of Surgery; Aug2024, Vol. 110 Issue 8, p4598-4607, 10p
Autor:
Yih-Jong Chern, Hsin-Yin Hsu, Yu-Jen Hsu, Le-Yin Hsu, Wen-Sy Tsai, Chun-Kai Liao, Bor-Kang Jong, Jeng-Fu You
Publikováno v:
Diseases of the Colon & Rectum; Jan2024, Vol. 67 Issue 1, p62-72, 11p
Autor:
Pushpanjali Gupta, Yenlin Huang, Prasan Kumar Sahoo, Jeng-Fu You, Sum-Fu Chiang, Djeane Debora Onthoni, Yih-Jong Chern, Kuo-Yu Chao, Jy-Ming Chiang, Chien-Yuh Yeh, Wen-Sy Tsai
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1398 (2021)
Colorectal cancer is one of the leading causes of cancer-related death worldwide. The early diagnosis of colon cancer not only reduces mortality but also reduces the burden related to the treatment strategies such as chemotherapy and/or radiotherapy.
Externí odkaz:
https://doaj.org/article/e3893b43230046aca690817150cf81b5
Autor:
Shih-Jung Lo, Shu-Huan Huang, I-Li Lai, Yih-Jong Chern, Yu-Jen Hsu, Chun-Kai Liao, Ching-Chung Cheng, Wen-Sy Tsai, Pao-Shiu Hsieh, Jeng-Fu You
Purpose The standard initial treatment for metastatic colorectal cancer (mCRC) remains debated. This study investigated whether upfront primary tumor resection (PTR) or upfront systemic therapy (ST) provides better survival outcomes for patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e6c2e70939cbbe7cd5da3c02477349c
https://doi.org/10.21203/rs.3.rs-2911520/v1
https://doi.org/10.21203/rs.3.rs-2911520/v1
Autor:
Chun-Kai Liao, Ya-Ting Kuo, Yu-Jen Hsu, Yih-Jong Chern, Yen-Lin Yu, Yueh-Chen Lin, Pao-Shiu Hsieh, Jy-Ming Chiang, Chien‐Yuh Yeh, Jeng-Fu You
Publikováno v:
International Journal of Colorectal Disease. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7bd9c282ee23c63df047f242bb580b9
https://doi.org/10.1007/s00384-023-04388-8
https://doi.org/10.1007/s00384-023-04388-8
Autor:
Ting-Yu Chiang, Hung-Chih Hsu, Yih-Jong Chern, Chun-Kai Liao, Yu-Jen Hsu, Wen-Sy Tsai, Pao-Shiu Hsieh, Yu-Fen Lin, Hsiu-Lan Lee, Jeng-Fu You
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1663
The primary treatment for metastatic colorectal cancer (mCRC) consists of targeted therapy and chemotherapy to improve survival. A molecular target drug with an anti-epidermal growth factor receptor (EGFR) antagonist is recommended when the RAS and B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3998c7cea5a7534f796c59edecd45bb3